Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|April 22, 2006
Serological cross reactivity between polyomavirus capsidsRaphael P Viscidi, Barbara ClaymanCancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 26, 2005
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative womenRaphael P Viscidi, Brad Snyder, Susan Cu-Uvin, et al.Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassaysRaphael P Viscidi, Dana E M Rollison, Emma Viscidi, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa RicaRaphael P Viscidi, Mark Schiffman, Allan Hildesheim, et al.The Journal of Infectious Diseases|December 16, 2003
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative womenRaphael P Viscidi, Linda Ahdieh-Grant, Michael F Schneider, et al.The Journal of Infectious Diseases|January 29, 2003
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative womenRaphael P Viscidi, Linda Ahdieh-Grant, Barbara Clayman, et al.Pageof 1